These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 17959889)
1. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features. Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889 [TBL] [Abstract][Full Text] [Related]
2. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary. Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877 [TBL] [Abstract][Full Text] [Related]
5. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549 [TBL] [Abstract][Full Text] [Related]
7. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. Lin CK; Chao TK; Yu CP; Yu MH; Jin JS APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589 [TBL] [Abstract][Full Text] [Related]
8. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910 [TBL] [Abstract][Full Text] [Related]
9. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas. Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867 [TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin. Sato S; Okamoto S; Ito K; Konno R; Yajima A Acta Cytol; 2000; 44(3):485-8. PubMed ID: 10834020 [No Abstract] [Full Text] [Related]
11. Loss of cables, a novel gene on chromosome 18q, in ovarian cancer. Dong Q; Kirley S; Rueda B; Zhao C; Zukerberg L; Oliva E Mod Pathol; 2003 Sep; 16(9):863-8. PubMed ID: 13679449 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression. Torng PL; Mao TL; Chan WY; Huang SC; Lin CT Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248 [TBL] [Abstract][Full Text] [Related]
13. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining. Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666 [TBL] [Abstract][Full Text] [Related]
14. Proliferative activity and p53 over-expression of ovarian epithelial tumors. Kuwata T; Kitagawa M; Takemura T; Hirokawa K Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593 [TBL] [Abstract][Full Text] [Related]
16. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772 [TBL] [Abstract][Full Text] [Related]
17. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR Cancer Cell; 2007 Apr; 11(4):321-33. PubMed ID: 17418409 [TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of elongation factor eEF1A2 in ovarian cancer. Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751 [TBL] [Abstract][Full Text] [Related]
19. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]